Stock 4519 CHUGAI PHARMACEUTICAL CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Chugai Pharmaceutical Co., Ltd

Equities

4519

JP3519400000

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-05-31 am EDT 		5-day change 1st Jan Change
4,781 JPY +1.90% Intraday chart for Chugai Pharmaceutical Co., Ltd +0.70% -10.50%
May. 23 Tech stocks lift Japan's Nikkei on boost from Nvidia's robust outlook RE
May. 14 Japan's Nikkei drifts sideways as more earnings, US CPI awaited RE

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Chugai Pharmaceutical : Personnel Changes
Chugai Pharmaceutical : Obtains Approval for FoundationOne Liquid CDx Cancer Genomic Profile to Provide Information on Detection of Copy Number Alterations of Cancer-Related Genes and bTMB Score
Tech stocks lift Japan's Nikkei on boost from Nvidia's robust outlook
Japan's Nikkei drifts sideways as more earnings, US CPI awaited
Chugai, NCCH, OMPU and MICIN Start Company-Sponsored Phase I Study in Oncology with a New Decentralized Clinical Trial Structure, Improving access to the clinical trial for patients far from the institution
Chugai Pharmaceutical Allots 594 Million Yen Worth of Shares as Restricted Stock Compensation
Chugai Pharmaceutical : Notice of Completion of Disposal of Treasury Shares as Restricted Stock Compensation Plan
Chugai Announces 2024 1st Quarter Results
Chugai Pharmaceutical's Parent Roche Logs Lower Q1 Sales; Stock Falls 5%
Chugai Pharmaceutical's Profit Slightly Up in Q1
Chugai Pharmaceutical : Q1 Results (Jan-Mar 2024)
Chugai Pharmaceutical Co., Ltd. Provides Dividend Guidance for the Second Quarter of Fiscal Year Ending December 31, 2024; Provides Dividend Guidance for the Year Ending December 31, 2024
Chugai Pharmaceutical : F. Hoffmann-La Roche Announces First Quarter Sales 2024
Chugai Pharmaceutical Co., Ltd. - Positive Phase III Results Showed Vabysmo Improved Vision for the First Time in Japanese in Angioid Streaks
Chugai Pharmaceutical Co., Ltd. - Relief Efforts Support for Earthquake off the Eastern Coast of Taiwan
Japan's Nikkei slips on caution ahead of US inflation data
Chugai Pharmaceutical to Allocate 594 Million Yen of Treasury Shares as Restricted Stock Compensation
Chugai Obtains Approval for FoundationOne CDx Cancer Genomic Profile to Be Used as a Companion Diagnostic for the AKT Inhibitor, Capivasertib for Advanced HR-positive, HER2-negative Breast Cancer
Chugai Pharmaceutical : Notice of Disposal of Treasury Shares as Restricted Stock Compensation Plan
Chugai Obtains Regulatory Approval for Vabysmo, the Only Bispecific Antibody in the Ophthalmology Field, for Additional Indication of Macular Edema Associated with Retinal Vein Occlusion
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4519 Stock
  4. News Chugai Pharmaceutical Co., Ltd
  5. Other languages